| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $5.65 (Beat by $0.8) |
| EPS GAAP Actual | $5.65 (Beat by $0.8) |
| Revenue Actual | $7.0374B |
| Revenue Surprise | Beat by $7037.4M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $5.12763 |
| EPS GAAP Estimate | $5.12763 |
| Revenue Estimate | $7.2745715B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 34.52 | 5.69 | 32.91619 | 37.13753 | 1 |
| Dec 2028 | 27.115 | 7.25 | 26.32212 | 28.1835 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.65 | 0.58733 | 7.0374B | 6.41% | -139.88M |
| FQ2 2025 (Jun 2025) | 2.23 | -2.78 | 6.9744B | 7.08% | -125.15M |
| FQ1 2025 (Mar 2025) | 4.5 | -0.12 | 6.6904B | 3.06% | -86.97M |
| FQ4 2024 (Dec 2024) | 4.66 | -0.15503 | 7.2132B | 6.18% | 296.66M |
| FQ3 2024 (Sep 2024) | 4.66 | -0.1876 | 6.5861B | -4.66% | -294.58M |
| FQ2 2024 (Jun 2024) | 3.2 | 1.85741 | 6.4804B | -6.32% | -5581.83M |
| FQ1 2024 (Mar 2024) | 4.53 | 4.53 | 6.4857B | 1.34% | 6485.7M |
| FQ4 2023 (Dec 2023) | 5.04 | 5.04 | 6.7674B | 1.04% | 6767.4M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
5.12763
Consensus Revenue Estimates
7.2745715B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 5.65 | -- | 5.52773 | 5.82616 | 2 |
| FQ3 2026 (Sep 2026) | 5.46 | -3.48 | 5.34184 | 5.63023 | 2 |
| FQ2 2026 (Jun 2026) | 3.91 | 42.97 | 3.82538 | 4.03191 | 3 |
| FQ1 2026 (Mar 2026) | 4.97 | 9.46 | 4.86244 | 5.12496 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 6.89B | -- | 6.77B | 7.05B | 3 |
| FQ3 2026 (Sep 2026) | 6.88B | -2.26 | 6.77B | 7.05B | 3 |
| FQ2 2026 (Jun 2026) | 6.57B | -6.22 | 6.46B | 6.72B | 3 |
| FQ1 2026 (Mar 2026) | 6.56B | -2.01 | 6.45B | 6.72B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
5
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.06267 | 5.65 | 0.58733 | 10.4% |
| FQ2 2025 (Jun 2025) | 5.01 | 2.23 | -2.78 | -124.66% |
| FQ1 2025 (Mar 2025) | 4.62 | 4.5 | -0.12 | -2.67% |
| FQ4 2024 (Dec 2024) | 4.81503 | 4.66 | -0.15503 | -3.33% |
| FQ3 2024 (Sep 2024) | 4.8476 | 4.66 | -0.1876 | -4.03% |
| FQ2 2024 (Jun 2024) | 1.34259 | 3.2 | 1.85741 | 58.04% |
| FQ1 2024 (Mar 2024) | 4.53 | 4.53 | 100% | |
| FQ4 2023 (Dec 2023) | 5.04 | 5.04 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $7.18B | $7.04B | $-139.88M | -1.99% |
| FQ2 2025 (Jun 2025) | $7.1B | $6.97B | $-125.15M | -1.79% |
| FQ1 2025 (Mar 2025) | $6.78B | $6.69B | $-86.97M | -1.3% |
| FQ4 2024 (Dec 2024) | $6.92B | $7.21B | $296.66M | 4.11% |
| FQ3 2024 (Sep 2024) | $6.88B | $6.59B | $-294.58M | -4.47% |
| FQ2 2024 (Jun 2024) | $12.06B | $6.48B | $-5581.83M | -86.13% |
| FQ1 2024 (Mar 2024) | $0B | $6.49B | $6485.7M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $6.77B | $6767.4M | 100% |